• English
  • Eesti

    The Estonian medicinal products market in third quarter 2019

    Printer-friendly version

    Estonian drug statistics is based on wholesalers’ reports. The statistics of human medicinal products includes sales to general and hospital pharmacies and to other institutions, i.e. state and scientific institutions. The statistics of veterinary medicinal products includes sales to general and veterinary pharmacies, veterinarians and to other institutions. The medicinal products market is expressed in wholesale prices which includes the price of the manufacturer and wholesaler’s mark-up and does not include the VAT.

    Human medicines

    In the third quarter of 2019 the medicinal products market increased 7.9% reaching to 84.0 million euros. Estonian human medicines market of previous five years shows also an increasing trend:

    Figure 1. Estonian human medicines market in third quarter 2015–2019

    Sales to general pharmacies were 58.4 million euros, sales to hospital pharmacies 24.4 million euros and sales to other institutions 1.1 million euros.

    Prescription sales covered most of the medicinal products market, being 72.4 million euros. The turnovers of over the counter sales and hospital package sales were 11.2 million euros and 0.5 million euros.

    Based on ATC classification, the most sold medicines by turnover, were antineoplastic and immunomodulating agents (18.5 million euros), antiinfectives for systemic use (11.6 million euros) and alimentary tract and metabolism medicines (9.8 million euros).

    Defined Daily Dose (DDD) is the assumed average dose per day for the drug used in its main indication in adults. Defined Daily Dose per thousand inhabitants a day (DDD/1000/day) expresses the proportion of the population within a defined area treated daily with certain drugs.

    According to DDD/1000/day the most consumed medicines in the third quarter of 2019 were cardiovascular system drugs (424 DDD/1000/day), alimentary tract and metabolism drugs (168 DDD/1000/day) and nervous system medicines (130 DDD/1000/day).

    In the third quarter of 2019, almost 3700 different medicinal preparation packages and 1200 active substances were marketed in Estonia.

    Veterinary medicines

    In the third quarter of 2019 the Estonian veterinary medicinal products market increased 0.7% compared to the same period in 2018 reaching to 3.65 million euros.

    The most sold medicines by turnover were antiinfectives for systemic use (0.91 million euros), followed by antiparasitic products (0.69 million euros) and immunologicals (0.65 million euros).

    89% of veterinary medicines were sold to the veterinarians or to the agricultural companies represented by a veterinarian, 6% to the veterinary pharmacies, 5% to the general pharmacies and 0.1% to other institutions (generally state- and scientific institutions).

    Figure 2. Estonian veterinary medicines market in third quarter 2015–2019